ministry of health pharmacy division january … 2017... · 2017-04-13 · determine hiv screening...

Months of Stock (MOS).

The contents of the different baskets are listed below:

ARV BASKET LOC EMHS BASKET LOC

Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) HC3 Recommended first line ACT (Artemether/Lumefantrine 20/120mg) HC2

Zidovudine /Lamivudine/Nevirapine (AZT/3TC/NVP) HC3 Cotrimoxazole 480mg HC2

Zidovudine/Lamivudine (AZT/3TC) HC3 Thearapeutic milk F75 (75Kcal/100ml) Hospital

Tenofovir/Lamivudine (TDF/3TC) HC3 Thearapeutic milk F100 (100Kcal/100ml) Hospital

Nevirapine (NVP) 200mg HC3 Ready to use Therapeutic feeds (RUTF) HC1

Efavirenz (EFV) 600mg HC3 Cotrimoxazole 960mg tablet HC3

Abacavir/Lamivudine (ABC/3TC) 60mg/30mg HC3 Chlorhexidine 20% HC2

Nevirapine (NVP) 50mg HC3 Bendroflumethiazide (Aprinox) 5mg HC3

Propranolol 40mg HC4

LAB BASKET LOC Nifedipine tablets 20mg HC3

Determine HIV Screening test HC2 Captopril 25mg Hospital

Stat -pack HIV Confirmatory rapid tests HC2 Metformin 500mg HC4

Unigold HIV RDT Tie-breaker test HC2 Glibenclamide 5mg HC4

CD4 reagent Specify HC4 Insulin short-acting HC4

Malaria Rapid Diagnostic tests HC2 Cardiac Asprin 75mg HC4

ZN reagent for AFB HC3

Blood 450 ml HC4

RMNCAH BASKET LOC

Depo- Provera HC2

Sulfadoxine/ Pyrimethamine tablet HC2

ORS Sachets with zinc tablet HC2Measles Vaccine HC2

Misoprostol 200mcg Tablet HC2

Amoxicillin dispersible 250mg tablet (For children) HC2

Ceftriaxone 1g Injection HC4

Oxytocin Injection HC3

Mama Kit HC2

TB BASKET LOC

RHZE blister strip HC3

RH blister strip 150/75mg HC3

KEY FINDINGS

4. Large percentage of overstocked facilities were:

a) Majority were Government and PNFP facilities

b) Over stocked commodities were mainly Depo-provera at 51% , Sulfadoxine Pyrimethamine at 41% and ACT (24 pack) at 40%

5. Commodities that stocked out were mainly Nevirapine 50mg at 68%, TB (RHZE and RH) at 55%, Misoprostol at 63%, Statpak and Unigold at 54% and 59% respectively

6. Redistribution of overstocked commodities at facility level can bring stock levels to; 6MoS for Depo-provera, 3 MoS for ACT's and 4MOS for Sulfadoxine/ Pyrimethamine tablet

2. Overall average percentage availability for the basket of 41 commodities was 88% and percentage of facilities with over 95% availability was 64% ; this was maintained as

from the previous quarter

3. Percentage of facilities with over 95% was highest for TB medicines at 75% (1322 / 1763) and lowest for RMNCAH at 57% (2216/3887)

lists of facilities that are overstocked and stocked out so that they can work with the

respective DHO's to oversee redistribution of these commodties and write to NMS to halt

supply of overstocked commodities to facilities that receive Kits

4. PD and RH division to streamline the procurement, distribution and monitoring of

reproductive health commodities

1. Overall, facility reporting rates decreased to 53%(3349/6362) from 64% (4021/6318) in the previous quarter of October-December 2016

ACTION POINTS

1. Pharmacy Department to follow up on non- reporting facilities through phone calls,

text messages on the PIP platform as a reminder to improving reporting rate

2. Pharmacy Department to implement the SOP on how to report on the 41 tracer EMHS

3. Pharmacy Department to provide disease programs and implementing partners with

Definition : This indicator measures the % of health facilities that reported having the basket of commodities available during the reporting period.

The report shows the availability of the different and overall baskets using two indicators i.e.

1) Average percentage availability of a basket of 41 commodities based on all reporting facilities in the previous quarter

Definition : Availability is measured as the number of days for which a specific commodity was in stock at the facility store during the reporting period.

2) Percentage of facilities that had over 95% availability of a basket of commodities in the previous quarter

This bi-monthly report on the facility stock status of the 41 tracer items (in different baskets) provides information about the stock situation of health facilities in the country

in order to inform the Ministry of Health and all stakeholders to make appropriate logistics decisions that ensure an effective health commodities supply chain.

The report shows the number and percentages of facilities that are appropriately stocked, over stocked or under stocked by level of care and ownership based on

The MOS highlights the number of months a product will last based on the present consumption rate.

It also further indicates facilities that have over 8 months of stock (MOS) broken down by level of care and ownership.

MINISTRY OF HEALTH

PHARMACY DIVISION

JANUARY-FEBRAURY 2017 FACILITY TRACER MEDICINES STOCK STATUS REPORT

A Publication of the Ministry of Health Uganda

January-February 2017 Facility Stock Status Report 1 of 18

Percentage availability for each item (EMHS basket) Percentage availability for each item (ARV basket)

Item n Std Dev Item n % availty Std Dev

ACT_AL 3828 12 AZT/3TC/NVP 1805 93 23

Bendrofluazide 1807 33 ABC/3TC 1741 90 26

Captopril 856 35 EFV 600mg 1798 92 23

Cardiac Asprin 952 41 NVP 200mg 1784 91 24

Chlorhexidine 20% 2743 35 NVP 50mg 1700 75 39

Cotrimoxazole 480mg 3777 25 TDF/3TC 1800 92 24

Cotrimoxazole 960mg 1945 24 TDF/3TC/EFV 2756 88 28

Glibenclamide 1012 30 AZT/3TC 1771 90 26

Insulin short-acting 885 38

Metformin 1025 30

Nifedipine tablets 1898 29

Propranolol 1034 39 Percentage availability for each item (TB basket)

RUTF 2357 38 Item n % availty Std Dev

678 38 RHZE 1742 88 29

Thearapeutic milk F75 680 38 RH 1711 86 30

Percentage availability for each item (RMNCAH basket) Percentage availability for each item (LAB basket)

Item n Std Dev Item n % availty Std Dev

Depo-provera 3667 24 MRDT 3697 93 19

Ceftriaxone 1g injection 2927 24 Blood 450 ml 820 79 38

Amoxicillin dispersable 125mg 1182 39 CD4 reagent 862 84 34

Mama kit 2743 36 Determine 3310 91 24

Measles vaccine 3410 20 Stat-pack 3123 83 32

Misoprostol 200mcg tablet 2732 32 Unigold 3005 82 34

ORS sachets with zinc tablet 3778 20 ZN reagent 1521 80 37

Oxytocin injection 1914 25

SP 3589 29

Comments: Availability indicators

AVAILABILITY INDICATORS

Thearapeutic milk F100

% availty

97

84

83

74

82

88

91

87

78

86

86

77

78

79

80

% availty

92

90

72

79

94

85

93

90

87

1. On average the basket of 41 commodities was available 88% of the time (79/90 days): consistent with the previous quarter of October-December2.On average 64% of health facilities reported over 95% availability of the basket of commodities.

87% 89%86%

88%90%

88% 88% 87% 88%90%

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

EMHS (15 items) ARV (8 items) TB (2 items) LAB (7 items) RMNCAH (9 items)

Avg %age availability of different baskets

Oct-Dec 2016 Jan-Feb 2017

62%

68%

75%

59%57%58%

67%

75%

61%57%

0%

10%

20%

30%

40%

50%

60%

70%

80%

EMHS (15 items) ARV (8 items) TB (2 items) LAB (7 items) RMNCAH (9 items)

%age of facilities with over 95% availability

Oct-Dec 2016 Jan-Feb 2017


District League Table1 (Facilities with over 95% availability by District) Continuation: District League Table (Facilities with over 95% availability by District)

Rank District EMHS ARV LAB RMNCAH TB Rank District EMHS ARV LAB RMNCAH TB Overall Avg1 Kaabong 100% 100% 100% 100% 100% 57 Mayuge 56% 50% 66% 56% 88% 63%2 Busia 100% 100% 97% 100% 100% 58 Adjumani 57% 74% 60% 43% 79% 62%3 Luuka 100% 100% 96% 96% 100% 59 Isingiro 49% 70% 53% 65% 73% 62%4 Kween 86% 100% 86% 91% 100% 60 Masaka 58% 67% 41% 68% 73% 61%5 Sheema 77% 80% 85% 94% 100% 61 Lwengo 41% 54% 46% 63% 100% 61%6 Rubirizi 94% 100% 78% 56% 100% 62 Kole 67% 60% 58% 58% 60% 61%7 Lira 84% 87% 84% 81% 90% 63 Serere 57% 62% 71% 48% 62% 60%8 Mbarara 90% 83% 74% 81% 89% 64 Kapchorwa 56% 43% 67% 47% 86% 60%9 Jinja 84% 94% 73% 70% 91% 65 Kitgum 44% 72% 50% 47% 86% 60%10 Buhweju 82% 88% 65% 76% 100% 66 Kabale 57% 65% 55% 56% 63% 59%11 Kaliro 80% 100% 88% 63% 75% 67 Kyenjojo 50% 69% 47% 50% 77% 59%12 Ntungamo 68% 81% 81% 78% 94% 68 Buliisa 36% 55% 45% 55% 100% 58%13 Kiboga 88% 70% 69% 69% 100% 69 Rakai 52% 83% 46% 37% 72% 58%14 Kampala 83% 77% 80% 75% 80% 70 Mitooma 59% 44% 67% 59% 57% 57%15 Kiryandongo 55% 78% 90% 70% 100% 71 Mbale 54% 66% 56% 46% 61% 57%16 Butambala 65% 87% 83% 70% 87% 72 Nakaseke 42% 67% 58% 63% 53% 57%17 Wakiso 77% 76% 74% 70% 86% 73 Namutumba 75% 29% 71% 58% 50% 56%18 Kisoro 58% 74% 76% 74% 100% 74 Koboko 38% 73% 50% 56% 63% 56%19 Kyankwanzi 72% 67% 63% 75% 100% 75 Sironko 50% 44% 56% 60% 69% 56%20 Moroto 87% 70% 53% 60% 100% 76 Nebbi 43% 59% 58% 51% 67% 55%21 Bushenyi 81% 89% 66% 56% 79% 77 Napak 57% 78% 43% 21% 71% 54%22 Masindi 63% 78% 83% 68% 76% 78 Sembabule 35% 65% 43% 48% 75% 53%23 Mubende 76% 78% 78% 56% 79% 79 Pader 68% 68% 32% 32% 64% 53%24 Kibuku 56% 81% 88% 56% 83% 80 Hoima 55% 50% 56% 44% 57% 52%25 Rukungiri 80% 64% 73% 65% 82% 81 Pallisa 31% 57% 44% 52% 76% 52%26 Mpigi 83% 82% 58% 74% 67% 82 Kamwenge 38% 58% 50% 42% 66% 51%27 Luwero 71% 77% 66% 70% 72% 83 Kamuli 51% 48% 62% 63% 27% 50%28 Bukomansimbi 62% 76% 62% 71% 83% 84 Lamwo 35% 44% 57% 35% 80% 50%29 Kibaale 69% 72% 68% 63% 83% 85 Kalangala 53% 53% 27% 27% 89% 50%30 Kabarole 58% 74% 62% 71% 88% 86 Apac 26% 80% 37% 37% 67% 49%31 Kotido 61% 81% 67% 61% 82% 87 Bundibugyo 32% 50% 50% 43% 70% 49%32 Kalungu 69% 83% 52% 69% 78% 88 Iganga 49% 40% 64% 51% 39% 49%33 Manafwa 73% 77% 59% 45% 95% 89 Amudat 63% 50% 13% 50% 67% 48%34 Kanungu 60% 82% 68% 53% 84% 90 Budaka 33% 54% 40% 20% 90% 47%35 Buyende 71% 71% 57% 48% 100% 91 Butaleja 38% 50% 46% 38% 64% 47%36 Kasese 61% 80% 73% 62% 72% 92 Zombo 47% 30% 39% 42% 70% 46%37 Namayingo 69% 78% 59% 56% 83% 93 Kaberamaido 36% 60% 40% 14% 75% 45%38 Lyantonde 74% 89% 53% 68% 60% 94 Ntoroko 43% 71% 57% 29% 25% 45%39 Nwoya 65% 88% 65% 47% 78% 95 Nakapiripirit 35% 53% 35% 41% 58% 45%40 Ibanda 48% 65% 77% 63% 83% 96 Arua 32% 35% 46% 43% 65% 44%41 Nakasongola 69% 54% 70% 66% 75% 97 Buvuma 36% 50% 36% 36% 60% 44%42 Gomba 53% 71% 42% 79% 88% 98 Kayunga 31% 40% 46% 35% 65% 43%43 Tororo 58% 78% 72% 51% 71% 99 Alebtong 29% 33% 56% 18% 71% 42%44 Soroti 60% 59% 61% 58% 91% 100 Kumi 38% 33% 40% 33% 60% 41%45 Katakwi 62% 69% 40% 69% 88% 101 Ngora 17% 42% 25% 25% 89% 39%46 Oyam 36% 90% 60% 50% 90% 102 Moyo 15% 18% 51% 46% 67% 39%47 Bulambuli 58% 64% 56% 58% 89% 103 Amolatar 23% 57% 31% 15% 67% 39%48 Mukono 70% 67% 53% 60% 72% 104 Mityana 25% 35% 37% 41% 47% 37%49 Bukwo 44% 88% 56% 75% 60% 105 Dokolo 25% 25% 50% 31% 50% 36%50 Agago 58% 79% 44% 50% 91% 106 Maracha 21% 36% 21% 29% 64% 34%51 Gulu 38% 69% 72% 58% 85% 107 Amuru 25% 41% 22% 19% 62% 34%52 Bugiri 74% 62% 74% 69% 42% 108 Kyegegwa 13% 23% 40% 27% 50% 31%53 Buikwe 67% 66% 57% 48% 83% 109 Bukedea 33% 29% 22% 22% 40% 29%54 Bududa 53% 63% 73% 47% 83% 110 Yumbe 17% 33% 29% 17% 45% 28%55 Total 58% 66% 60% 57% 75% 111 Amuria 6% 21% 29% 33% 50% 28%56 Kiruhura 55% 68% 53% 70% 71% 112 Abim 5% 10% 5% 5% 50% 15%57 Mayuge 56% 50% 66% 56% 88% 113 Otuke 0% 0% 13% 7% 43% 13%

100%99%99%93%87%86%

DISTRICT LEAGUE TABLE

85%83%

Overall Avg

82%82%81%80%79%79%79%78%77%76%75%74%74%74%74%73%73%73%71%71%71%70%70%70%70%70%70%70%69%69%68%67%67%67%66%66%

64%63%63%63%

65%65%65%65%65%64%64%64%64%


Ownership

No. Row % No. Row % No. Row % No. Row % No. Row % Govt PNFP PFP NGOs Not Assigned Total

Recommended first line ACT (Artemether/Lumefantrine 100/200mg) ACT (Artemether/Lumefantrine 100/200mg)

Level of Care Level

Clinic 26 31 37 45 8 10 12 15 83 100 Clinic 0 2 4 0 2 8

HC 2s 261 14 597 31 295 15 783 40 1936 100 HC 2s 382 73 3 5 20 483

HC 3s 147 13 336 31 159 15 457 42 1099 100 HC 3s 223 74 1 1 1 300

HC 4s 18 11 42 25 24 14 83 50 167 100 HC 4s 50 6 0 0 1 57

General Hosp 19 19 28 28 15 15 39 39 101 100 General Hosp 7 12 1 1 0 21

Regional Hosp 2 18 7 64 0 0 2 18 11 100 Regional Hosp 1 0 0 0 0 1

National Ref. Hosp 1 100 0 0 0 0 0 0 1 100 Not Assigned 0 0 0 0 11 11

Not Assigned 20 21 44 46 10 10 22 23 96 100 Total 663 167 9 7 35 881

Total 494 14 1091 31 511 15 1398 40 3494 100

Owner Comments: ACTs

Govt 304 12 742 30 379 15 1041 42 2466 100

PNFP 88 15 149 25 87 15 277 46 601 100

PFP 55 27 111 55 18 9 18 9 202 100

NGOs 12 28 16 37 6 14 9 21 43 100

Not Assigned 35 19 73 40 21 12 53 29 182 100

Total 494 14 1091 31 511 15 1398 40 3494 100

How many MOS does over stock (> 8MOS) at push facilities (HC2s and HC3s) translate into at higher levels for ACTs?

Ownership


Bendrofluazide (Aprinox) 5mg Bendrofluazide (Aprinox) 5mg

Level of Care Level

Clinic 31 57 13 24 7 13 3 6 54 100 Clinic 0 2 0 0 0 2

HC 2s 182 67 33 12 25 9 33 12 273 100 HC 2s 0 13 4 2 3 22

HC 3s 376 55 78 11 73 11 159 23 686 100 HC 3s 87 14 3 0 1 105

HC 4s 59 49 18 15 20 17 24 20 121 100 HC 4s 17 1 0 0 0 18


Regional Hosp 4 36 2 18 3 27 2 18 11 100 National Ref. Hosp 1 0 0 0 0 1

Not Assigned 49 68 11 15 8 11 4 6 72 100 Not Assigned 0 0 0 0 3 3

Total 731 56 168 13 154 12 243 19 1296 100 Total 107 32 7 2 7 155

Owner Comments: Bendrofluazide (Aprinox) 5mg

Govt 351 54 70 11 66 10 160 25 647 100 56% of the facilities were stocked out on Aprinox this was a decrease from 77% in the previous quarter October-December 2016

PNFP 206 55 53 14 57 15 57 15 373 100 Mainly HC3s and HC2s were stocked out

PFP 72 56 27 21 17 13 13 10 129 100 Government owned HC3s formed the larger part of overly stocked (>8 MOS) facilities

NGOs 20 65 3 10 5 16 3 10 31 100 HC2s and clinics with Aprinox are private facilities.

Not Assigned 82 71 15 13 9 8 10 9 116 100 Overall median MoS is 2 months with range (0,71) MoS

Total 731 56 168 13 154 12 243 19 1296 100

Ownership


Captopril 25mg Captopril 25mg

Level of Care Level

Clinic 30 61 10 20 2 4 7 14 49 100 Clinic 0 1 3 0 0 4

HC 2s 183 74 23 9 19 8 24 10 249 100 HC 2s 0 9 3 2 0 14

HC 3s 115 64 25 14 23 13 17 9 180 100 HC 3s 0 14 1 0 0 15

HC 4s 3 23 4 31 1 8 5 39 13 100 HC 4s 0 3 0 0 0 3


Regional Hosp 10 91 1 9 0 0 0 0 11 100 Not Assigned 0 0 0 0 2 2


Total 442 67 92 14 61 9 69 10 664 100

Owner Comments: Captopril 25mg

Govt 44 92 2 4 0 0 2 4 48 100 67% of the facilities were stocked out, this was a decrease from 68% in the previous quarter of October- December 2016

PNFP 218 62 45 13 44 13 43 12 350 100 Overall median MoS is 2 months with range (0,37) MoS

PFP 74 60 27 22 7 6 16 13 124 100 Lower level facilities (Clinics, HC2s, HC3s and HC4s) with Captopril were private facilities

NGOs 21 70 3 10 3 10 3 30 100

Not Assigned 85 76 15 13 7 6 5 5 112 100

Total 442 67 92 14 61 9 69 10 664 100

No. of facilities with over 8 MOS

0 <2 2-4 >4 Total

0 <2 2-4 >4 Total

Months of Stock

The median stock on hand for the over stocked (>8MOS) push facilities was 28,080 tablets (1652 doses).

The median AMC of ACTs at HC4s, General Hospitals and Regional Referral Hospitals were 4680, 2997 and 26,640 respectively.

Therefore; computing MOS using the above figures; we find that the stock at push facilities (with over 8 MOS) translates into: 6 MOS at HC4s; 9 MOS at General Hospitals and 1 MOS at RRHs

Months of Stock No. of facilities with over 8 MOS

Overall median MoS is 3 months with range (0,67) MoS


0 <2 2-4 >4 Total

EMHS BASKET

Note: No: is the number of facilities Note: Red shows the stock levels are stocked out or overstocked and need attention

Row%: is the percentage of facilities Green: means the stock levels are adequate

Only 14% of facilities were stocked out, an increase from 12% complete stock out in the previous quarter October-December 2016

At central level (NMS) had low stock levels in January- February 2017 0.3 and 1.4 MoS respectively

40% of facilities were overstocked (>4), 25% had >8 MOS

Govt and PNFP owned HC2s and HC3s still formed the marjority of the overstocked (>8 MOS) facilities


Ownership


Cardiac Asprin 75/80mg Cardiac Asprin 75/80mg

Level of Care Level

Clinic 33 61 13 24 5 9 3 6 54 100 Clinic 0 1 1 0 0 2

HC 2s 213 86 15 6 12 5 8 3 248 100 HC 2s 0 1 1 1 0 3

HC 3s 130 77 14 8 10 6 15 9 169 100 HC 3s 0 7 1 0 0 8

HC 4s 122 92 7 5 3 2 1 1 133 100 HC 4s 1 0 0 0 0 1



National Ref. Hosp 1 100 0 0 0 0 0 0 1 100 Total 1 12 4 1 3 21

Not Assigned 47 70 11 16 6 9 3 5 67 100

Total 617 79 76 10 43 6 41 5 777 100

Owner Comments: Cardiac Asprin 75/80mg

Govt 167 98 2 1 0 0 1 1 170 100 79% of health facilities were stocked out; this was 13% decrease from 92% in the previous quarter October-December 2016

PNFP 268 77 31 9 23 7 28 8 350 100 HC4s and RRH were the majority of stocked out facilities.

PFP 75 62 28 23 11 9 7 6 121 100 Lower level facilities (Clinics, HC2s, HC3s) with Cardiac Aspirin were private facilities

NGOs 24 86 2 7 1 4 1 4 28 100 Overall median MoS is 1MoS with range (0,25) MoS

Not Assigned 83 77 13 12 8 7 4 4 108 100

Total 617 79 76 10 43 6 41 5 777 100

Ownership


Chlorhexidine 20% Chlorhexidine 20%

Level of Care Level

Clinic 37 77 6 13 4 8 1 2 48 100 HC 2s 26 1 2 0 3 32

HC 2s 686 69 98 10 144 15 67 7 995 100 HC 3s 44 9 1 0 1 55

HC 3s 452 58 99 13 114 15 109 14 774 100 HC 4s 8 1 0 0 0 9

HC 4s 72 53 33 24 11 8 20 15 136 100 General Hosp 2 3 0 1 0 6

General Hosp 45 55 19 23 8 10 10 12 82 100 Regional Hosp 1 0 0 0 0 1



Total 1344 64 271 13 287 14 211 10 2113 100

Owner Comments: Chlorhexidine 20%

Govt 925 62 160 11 225 15 175 12 1485 100 Majority of facilities (64%) were stocked out ; mainly Regional Hospitals and PFP Clinics

PNFP 246 66 60 16 43 12 22 6 371 100 Overall median MoS is 2months with range (0,36) MoS

PFP 78 67 25 22 8 7 5 4 116 100

NGOs 19 66 5 17 3 10 2 7 29 100

Not Assigned 76 68 21 19 8 7 7 6 112 100

Total 1344 64 271 13 287 14 211 10 2113 100

Ownership


Cotrimoxazole 480mg Cotrimoxazole 480mg

Level of Care Level

Clinic 34 42 32 40 6 7 9 11 81 100 Clinic 0 1 4 0 3 8

HC 2s 370 20 586 31 375 20 537 29 1868 100 HC 2s 228 34 4 5 12 283

HC 3s 201 19 314 30 199 19 349 33 1063 100 HC 3s 176 25 1 1 2 205

HC 4s 27 17 67 41 33 20 37 23 164 100 HC 4s 17 2 0 0 1 20



National Ref. Hosp 0 0 0 0 0 0 1 100 1 100 National Ref. Hosp 1 0 0 0 0 1


Total 697 21 1066 32 646 19 967 29 3376 100 Total 431 66 9 6 27 539

Owner Comments: Cotrimoxazole 480mg

Govt 383 16 741 30 524 22 788 32 2436 100 19% of facilities had appropriate stock, this was an increase from 12% from the previous quarter

PNFP 189 35 167 31 71 13 112 21 539 100 Only 21% of facilities were stocked out, this was a drop from 28% in the previous quarter October-December 2016

PFP 63 34 89 48 17 9 17 9 186 100 Mainly General hospitals and PNFP Clinics were stocked out.

NGOs 14 34 9 22 7 17 11 27 41 100 Government owned HC2s and HC3s formed the larger part of the overstocked (>8MOS) facilities

Not Assigned 48 28 60 35 27 16 39 22 174 100 Overall median MoS is 2months with range (0,52) MoS

Total 697 21 1066 32 646 19 967 29 3376 100

Months of Stock No of facilities with over 8 MOS

0 <2 2-4 >4 Total


0 <2 2-4 >4 Total


0 <2 2-4 >4 Total


Ownership


Cotrimoxazole 960mg Cotrimoxazole 960mg

Level of Care Level

Clinic 25 42 20 34 9 15 5 9 59 100 Clinic 0 0 1 2 0 3

HC 2s 192 64 40 13 26 9 41 14 299 100 HC 2s 0 14 1 4 3 22

HC 3s 226 23 310 31 195 19 274 27 1006 100 HC 3s 119 23 1 0 0 143

HC 4s 24 15 79 48 25 15 38 23 166 100 HC 4s 15 0 0 0 0 15




Total 541 32 494 29 279 16 389 23 1704 100

Owner Comments: Cotrimoxazole 960mg

Govt 188 19 337 34 184 19 275 28 985 100

PNFP 173 39 111 25 66 15 91 21 441 100

PFP 78 57 31 23 19 14 10 7 138 100

NGOs 14 44 5 16 5 16 8 25 32 100

Not Assigned 88 81 10 9 5 5 6 6 109 100

Total 541 32 494 29 279 16 390 23 1705 100

Ownership


Glibenclamide 5mg Glibenclamide 5mg

Level of Care Level

Clinic 29 55 17 32 5 9 2 4 53 100 Clinic 0 0 1 0 0 1

HC 2s 188 74 28 11 16 6 23 9 255 100 HC 2s 0 7 2 2 0 11

HC 3s 112 62 21 12 24 13 25 14 182 100 HC 3s 0 17 0 0 0 17

HC 4s 29 21 44 32 28 20 38 27 139 100 HC 4s 22 2 0 0 0 24




Total 428 54 151 19 103 13 117 15 799 100 Total 33 29 3 2 1 68

Owner Comments: Glibenclamide 5mg

Govt 32 18 56 32 34 19 52 30 175 100 Stockedout facilities decreased to 54% from 81% in the previous quarter October-December 2016

PNFP 221 63 39 11 44 13 48 14 352 100 Stockouts were mainly in NGO HC2s

PFP 72 55 37 29 14 11 7 5 130 100

NGOs 20 65 4 13 2 7 5 16 31 100 Govt owned HC4s and PNFP HC3s were the most over stocked with Glibenclamide (>8 MOS)

Not Assigned 83 74 15 13 9 8 5 5 112 100 Overall median MoS is 2months with range (0,42) MoS

Total 428 54 151 19 103 13 117 15 799 100

Ownership


Insulin short-acting Insulin short-acting

Level of Care Level

Clinic 36 82 6 14 1 2 1 2 44 100 Clinic 0 0 1 0 0 1

HC 2s 225 95 7 3 3 1 2 1 237 100 HC 2s 0 1 0 1 1 2

HC 3s 147 93 5 3 3 2 3 2 158 100 HC 3s 0 0 0 0 0 0

HC 4s 87 70 13 10 10 8 15 12 125 100 HC 4s 10 2 0 0 0 12


Regional Hosp 5 46 3 27 0 0 3 27 11 100 Total 15 10 1 1 1 27

National Ref. Hosp 0 0 1 100 0 0 0 0 1 100

Not Assigned 53 95 1 2 1 2 1 2 56 100

Total 594 83 53 7 26 4 41 6 714 100

Owner Comments: Insulin short-acting

Govt 106 66 20 12 14 9 21 13 161 100

PNFP 283 88 17 5 7 2 16 5 323 100 of October-December 2016

PFP 91 84 14 13 3 3 1 1 109 100

NGOs 23 96 0 0 0 0 1 4 24 100

Not Assigned 91 94 2 2 2 2 2 2 97 100

Total 594 83 53 7 26 4 41 6 714 100

83% of facilities were stocked out, mainly NGO and PNFP HC2s and HC3s. This was a 10% decrease from 93% from the previous quarter

Lower level facilities (Clinics, HC2s, HC3s) with Cardiac Aspirin were private facilities

Overall median MoS is 1 month with range (0,52) MoS

No of facilities with over 8 MOS

0 <2 2-4 >4 Total

0 <2 2-4 >4 Total

Months of Stock

32% of facilities were stocked out ; mainly PFP HC2s

Government owned HC3s were overly stocked (>8 MOS) facilities

Overall median MoS is 2months with range (0,64) MoS



0 <2 2-4 >4 Total


Ownership


Metformin 500mg Metformin 500mg

Level of Care Level

Clinic 31 56 20 36 0 0 4 7 55 100 Clinic 0 1 2 0 0 3

HC 2s 185 68 38 14 27 10 21 8 271 100 HC 2s 0 5 4 1 2 12

HC 3s 109 56 32 17 25 13 28 14 194 100 HC 3s 0 15 0 1 0 16

HC 4s 44 30 60 41 21 15 20 14 145 100 HC 4s 10 0 0 0 0 10




Total 444 53 204 24 103 12 91 11 842 100

Owner Comments: Metformin 500mg

Govt 52 28 73 40 30 16 27 15 183 100

PNFP 226 60 59 16 50 13 43 11 378 100

PFP 70 51 43 31 14 10 11 8 138 100

NGOs 19 61 6 19 2 7 4 13 31 100 Lower level facilities (Clinics, HC2s, HC3s) with Metmorfin were private facilities

Not Assigned 77 68 23 20 7 6 6 5 113 100 Overall median MoS is 1 month with range (0,56) MoS

Total 444 53 204 24 103 12 91 11 842 100

Ownership


Nifedipine tablets 20mg Nifedipine tablets 20mg

Level of Care Level

Clinic 28 47 19 32 8 13 5 8 60 100 Clinic 0 1 2 0 0 3

HC 2s 157 50 69 22 49 16 37 12 312 100 HC 2s 0 12 4 0 2 18

HC 3s 348 43 161 20 125 15 180 22 814 100 HC 3s 90 13 1 1 0 105

HC 4s 57 38 50 34 15 10 27 18 149 100 HC 4s 14 1 0 0 0 15



National Ref. Hosp 0 0 0 0 0 0 1 100 1 100 Not Assigned 0 0 0 0 2 2


Total 656 43 366 24 225 15 275 18 1522 100

Owner Comments: Nifedipine tablets 20mg

Govt 339 43 167 21 105 13 183 23 794 100

PNFP 167 40 109 26 77 19 62 15 415 100

PFP 64 42 48 31 25 16 17 11 154 100

NGOs 18 56 5 16 6 19 3 9 32 100

Not Assigned 68 54 37 29 12 9 10 8 127 100

Total 656 43 366 24 225 15 275 18 1522 100

Ownership


Propranolol 40mg Propranolol 40mg

Level of Care Level

Clinic 32 59 10 19 5 9 7 13 54 100 Clinic 0 2 3 0 0 5

HC 2s 173 64 37 14 34 13 26 10 270 100 HC 2s 0 7 2 2 0 11

HC 3s 99 56 29 17 21 12 27 15 176 100 HC 3s 0 16 2 0 0 18

HC 4s 113 89 3 2 3 2 8 6 127 100 HC 4s 2 3 0 0 0 5




Not Assigned 42 58 20 27 6 8 5 7 73 100

Total 526 66 106 13 79 10 86 11 797 100

Owner Comments: Propranolol 40mg

Govt 161 94 2 1 3 2 6 4 172 100

PNFP 200 57 46 13 47 13 60 17 353 100

PFP 70 53 32 24 19 14 11 8 132 100

NGOs 16 64 3 12 3 12 3 12 25 100

Not Assigned 79 69 23 20 7 6 6 5 115 100

Total 526 66 106 13 79 10 86 11 797 100

PNFP HC2s and HC3s were over (>8 MOS) stocked

Lower level facilities (Clinics, HC2s, HC3s) with Propranolol were private facilities


0 <2 2-4 >4 Total

Majority of facilities were stocked out (66%); this was a decrease from 85% in the previous quarter October-December 2016

Majority of facilities were either stocked out or under stocked (67%)

Govt HC3s and PNFP HC2s and HC3s were the most over stocked (>8 MOS)

Lower level facilities (Clinics and HC2s) with Nifedipine were private facilities



of October -December 2016

Facilities mainly stocked out were HC2s and PNFPs


0 <2 2-4 >4 Total

0 <2 2-4 >4 Total

77% of the facilities were either stocked out or understocked; this was a 13% decrease from 90% in previous quarter



Ownership


Ready to use Therapeutic feeds (RUTF) Ready to use Therapeutic feeds (RUTF)

Level of Care Level

Clinic 40 95 0 0 1 2 1 2 42 100 Clinic 13 0 0 0 0 13

HC 2s 845 92 42 5 12 1 23 3 922 100 HC 2s 32 7 0 1 0 40

HC 3s 544 73 87 12 43 6 67 9 741 100 HC 3s 12 1 0 0 0 13

HC 4s 75 57 22 17 17 13 18 14 132 100 HC 4s 4 3 0 0 0 7




Total 1606 81 173 9 83 4 128 6 1990 100

Owner Comments: Ready to use Therapeutic feeds (RUTF)

Govt 1131 79 135 9 65 5 102 7 1433 100

PNFP 269 79 35 10 12 4 23 7 339 100 NMS is currently not procuring this commodity

PFP 97 100 0 0 0 0 0 0 97 100

NGOs 20 77 2 8 2 8 2 8 26 100

Not Assigned 89 94 1 1 4 4 1 1 95 100

Total 1606 81 173 9 83 4 128 6 1990 100

Ownership


Thearapeutic milk F100 (100Kcal/100ml) Thearapeutic milk F100 (100Kcal/100ml)

Level of Care Level

Clinic 39 100 0 0 0 0 0 0 39 100 HC 2s 0 1 0 0 0 1

HC 2s 226 100 0 0 0 0 1 0 227 100 General Hosp 3 2 0 0 0 5

HC 3s 150 99 1 1 0 0 0 0 151 100 Regional Hosp 2 0 0 0 0 2

HC 4s 7 88 0 0 1 13 0 0 8 100 Total 5 3 0 0 0 8

General Hosp 62 81 8 10 2 3 5 7 77 100

Regional Hosp 3 30 3 30 2 20 2 20 10 100

Not Assigned 53 98 0 0 0 0 1 2 54 100

Total 540 95 12 2 5 1 9 2 566 100

Owner Comments: Thearapeutic milk F100 (100Kcal/100ml)

Govt 28 64 9 21 2 5 5 11 44 100

PNFP 305 97 2 1 3 1 3 1 313 100

PFP 94 99 1 1 0 0 0 0 95 100

NGOs 22 100 0 0 0 0 0 0 22 100 NMS is currently not procuring this commodity

Not Assigned 91 99 0 0 0 0 1 1 92 100

Total 540 95 12 2 5 1 9 2 566 100

Ownership


Thearapeutic milk F75 (75Kcal/100ml) Thearapeutic milk F75 (75Kcal/100ml)

Level of Care Level

Clinic 39 100 0 0 0 0 0 0 39 100 HC 2s 0 1 0 0 0 1

HC 2s 224 100 0 0 0 0 1 0 225 100 General Hosp 5 1 0 0 0 6

HC 3s 150 99 1 1 0 0 0 0 151 100 Regional Hospital 3 0 0 0 0 3

HC 4s 6 67 0 0 3 33 0 0 9 100 Total 8 2 0 0 0 10

General Hosp 59 73 3 4 8 10 11 14 81 100

Regional Hosp 2 22 1 11 3 33 3 33 9 100

Not Assigned 53 96 0 0 1 2 1 2 55 100

Total 533 94 5 1 15 3 16 3 569 100

Owner Comments: Thearapeutic milk F75 (75Kcal/100ml)

Govt 26 58 2 4 7 16 10 22 45 100 Majority of facilities were stocked out (94%); mainly PFP and PNFP

PNFP 303 96 2 1 6 2 5 2 316 100

PFP 93 99 1 1 0 0 0 0 94 100 NMS is currently not procuring this commodity

NGOs 20 95 0 0 1 5 0 0 21 100

Not Assigned 91 98 0 0 1 1 1 1 93 100

Total 533 94 5 1 15 3 16 3 569 100

0 <2 2-4 >4 Total


Lower level facilities (Clinics, HC2s, HC3s, HC4s) with Therapeutic milk F100 were private facilities



0 <2 2-4 >4 Total

95% of facilities were stocked out, mainly PNFP and NGO facilities

UNICEF is distributing these commodities


0 <2 2-4 >4 Total

Overall median MOS is 1 month with range(0,57)





Ownership


Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/600mg TDF/3TC/EFV 300mg/300mg/600mg

Level of Care Level

Clinic 31 55 14 25 5 9 6 11 56 100 Clinic 0 0 2 1 0 3

HC 2s 787 80 95 10 38 4 61 6 981 100 HC 2s 19 6 4 1 0 30

HC 3s 195 19 328 32 199 20 299 29 1021 100 HC 3s 134 18 0 0 0 152

HC 4s 29 18 52 32 32 20 50 31 163 100 HC 4s 28 0 0 0 0 28




Total 1109 46 533 22 302 13 446 19 2390 100

Owner Comments: TDF/3TC/EFV 300mg/300mg/600mg

Govt 766 45 392 23 205 12 355 21 1718 100 TDF/3TC/EFV 300mg/300mg/600mg was either stocked out or under stocked in 68% of the facilities that reported

PNFP 160 38 109 26 82 19 73 17 424 100 The Dec'16-Jan'17 ARV Bi-monthly report indicated 46% of facilities either understocked or stocked out

PFP 76 66 19 16 8 7 13 11 116 100 Government facilities were the majority with stock levels over 8 MOS

NGOs 15 48 7 23 6 19 3 10 31 100 Overall median MoS is 3 months with range (0,41) MoS

Not Assigned 92 91 6 6 1 1 2 2 101 100

Total 1109 46 533 22 302 13 446 19 2390 100

Ownership


Zidovudine /Lamivudine/Nevirapine (AZT/3TC/NVP) Zidovudine /Lamivudine/Nevirapine (AZT/3TC/NVP)

Level of Care Level

Clinic 28 56 19 38 1 2 2 4 50 100 Clinic 0 2 5 1 0 8

HC 2s 200 82 15 6 13 5 16 7 244 100 HC 2s 127 16 0 2 1 146

HC 3s 176 19 257 28 193 21 291 32 917 100 HC 3s 16 1 0 0 0 17

HC 4s 16 10 54 34 40 26 47 30 157 100 HC 4s 2 4 2 0 0 8




Total 490 32 381 25 274 18 388 25 1533 100 Total 147 23 7 3 2 182

Owner Comments: Zidovudine /Lamivudine/Nevirapine (AZT/3TC/NVP)

Govt 136 15 277 30 197 21 308 34 919 100

PNFP 171 45 84 22 66 17 58 15 379 100 The Dec'16-Jan'17 ARV Bi-monthly report indicated majority (53%) of facilities had over 4MoS

PFP 81 74 9 8 8 7 12 11 110 100

NGOs 14 48 7 24 2 7 6 21 29 100

Not Assigned 88 91 4 4 1 1 4 4 97 100

Total 490 32 381 25 274 18 388 25 1533 100

Ownership


Zidovudine/Lamivudine (AZT/3TC) 300mg/150mg Zidovudine/Lamivudine (AZT/3TC) 300mg/150mg

Level of Care Level

Clinic 28 62 11 24 3 7 3 7 45 100 Clinic 0 0 1 0 0 1

HC 2s 205 88 7 3 10 4 12 5 234 100 HC 2s 0 4 1 0 2 7

HC 3s 229 29 155 20 131 17 270 34 785 100 HC 3s 143 18 0 0 0 161

HC 4s 23 16 36 25 27 19 60 41 146 100 HC 4s 32 2 0 0 1 35




Not Assigned 53 98 1 2 0 0 0 0 54 100

Total 561 41 239 18 195 14 373 27 1368 100

Owner Comments: Zidovudine/Lamivudine (AZT/3TC) 300mg/150mg

Govt 179 23 168 21 137 17 309 39 793 100

PNFP 194 55 58 16 48 14 53 15 353 100

PFP 81 80 7 7 6 6 7 7 101 100 The Dec'16-Jan'17 ARV Bi-monthly report indicated majority (57%) of facilities had over 4MoS

NGOs 18 72 3 12 3 12 1 4 25 100

Not Assigned 89 93 3 3 1 1 3 3 96 100

Total 561 41 239 18 195 14 373 27 1368 100

Govt owned HC3s and HC4s still formed the largest part of the over stocked facilities


0 <2 2-4 >4 Total

59% of facilities that reported were either out of stock or understocked; mainly PFP

50% of facilities were either understocked or overstocked


There is a positive correaltion (0.3) between consumption and patient numbers



0 <2 2-4 >4 Total

ARV BASKET


0 <2 2-4 >4 Total


Ownership


Tenofovir/Lamivudine (TDF/3TC) 300mg/300mg Tenofovir/Lamivudine (TDF/3TC) 300mg/300mg

Level of Care Level

Clinic 28 60 11 23 4 9 4 9 47 100 Clinic 0 0 1 1 0 2

HC 2s 203 83 17 7 5 2 19 8 244 100 HC 2s 0 8 3 0 0 11

HC 3s 249 29 212 24 171 20 238 27 870 100 HC 3s 123 16 0 1 0 140

HC 4s 24 15 48 30 31 20 55 35 158 100 HC 4s 24 2 0 0 0 26




Not Assigned 53 95 2 4 0 0 1 2 56 100

Total 577 39 339 23 233 16 333 23 1482 100 Comments: Tenofovir/Lamivudine (TDF/3TC) 300mg/300mg

Owner

Govt 203 23 251 29 159 18 266 30 879 100

PNFP 186 50 66 18 67 18 52 14 371 100 At central level, it was appropriately stocked at 7.3 MoS at NMS and 5.9 MoS at JMS

PFP 83 78 9 9 5 5 9 9 106 100

NGOs 16 57 6 21 2 7 4 14 28 100

Not Assigned 89 91 7 7 0 0 2 2 98 100

Total 577 39 339 23 233 16 333 23 1482 100

<2 2-4 >4 Ownership


Nevirapine (NVP) 200mg Nevirapine (NVP) 200mg

Level of Care Level

Clinic 29 59 14 29 2 4 4 8 49 100 Clinic 0 0 3 0 0 3

HC 2s 204 86 8 3 5 2 19 8 236 100 HC 2s 0 6 4 2 2 14

HC 3s 214 28 138 18 114 15 292 39 758 100 HC 3s 149 18 0 2 1 170

HC 4s 18 12 52 36 13 9 63 43 146 100 HC 4s 33 2 0 0 0 35




Total 542 40 236 18 153 11 415 31 1346 100

Owner Comments: Nevirapine (NVP) 200mg

Govt 171 22 166 22 104 14 330 43 771 100

PNFP 186 53 59 17 39 11 65 19 349 100

PFP 82 79 4 4 6 6 12 12 104 100

NGOs 18 64 5 18 1 4 4 14 28 100


Total 543 40 236 18 153 11 415 31 1347 100

Ownership


Nevirapine (NVP) 50mg Nevirapine (NVP) 50mg

Level of Care Level

Clinic 30 67 9 20 3 7 3 7 45 100 Clinic 0 1 1 0 0 2

HC 2s 209 91 4 2 6 3 12 5 231 100 HC 2s 0 3 2 1 0 6

HC 3s 461 64 86 12 76 11 102 14 725 100 HC 3s 38 14 0 4 0 56

HC 4s 81 60 20 15 10 8 23 17 134 100 HC 4s 9 0 0 0 0 9



Not Assigned 54 95 3 5 0 0 0 0 57 100 51 26 3 5 0 85

Total 881 68 144 11 102 8 163 13 1290 100 Total

Owner Comments: Nevirapine (NVP) 50mg

Govt 490 67 85 12 62 9 94 13 731 100

PNFP 198 58 48 14 36 11 58 17 340 100

PFP 86 90 3 3 2 2 5 5 96 100

NGOs 16 59 4 15 1 4 6 22 27 100 Stocked out at Central level (NMS)


Total 882 68 144 11 102 8 163 13 1291 100

PFP facilities were the majority of stocked out facilities (90%)

Government owned HC3s most over (>4MOS) stocked facilities

0 <2 2-4 >4 Total

68% of facilities were completely stocked out; this was a decrease from 78% in the previous quarter of October-December

Stocked out facilities decreased to 40% from 57% in the previous quarter of October-December 2016.

31% of facilities had > 4MoS mainly Regional hospitals

Govt facilities were the most over stocked facilities

At Central level, NVP 200mg was appropriately stocked at NMS at 7.1 MoS in Dcember

There is a positive correaltion (0.2) between consumption and patient numbers


62% of facilities were either stocked out or understocked; mainly PFP facilities.

Govt owned HC3s and HC4s are the most over stocked facilities



0 Total


0 <2 2-4 >4 Total


Ownership


Efavirenz (EFV) 600mg Efavirenz (EFV) 600mg

Level of Care Level

Clinic 30 63 10 21 3 6 5 10 48 100 Clinic 0 0 2 1 1 4

HC 2s 206 87 13 6 5 2 14 6 238 100 HC 2s 0 6 1 1 1 9

HC 3s 230 27 249 29 129 15 254 30 862 100 HC 3s 133 20 0 0 0 153

HC 4s 28 18 50 33 31 20 43 28 152 100 HC 4s 24 3 0 0 0 27




Total 567 39 358 25 199 14 338 23 1462 100

Owner Comments: Efavirenz (EFV) 600mg

Govt 191 22 286 33 145 17 259 29 881 100

PNFP 184 53 58 17 45 13 61 18 348 100

PFP 83 79 7 7 4 4 11 11 105 100

NGOs 19 66 2 7 3 10 5 17 29 100


Total 567 39 358 25 199 14 339 23 1463 100

Ownership


Abacavir/Lamivudine (ABC/3TC) 60mg/30mg (Paediatric) Abacavir/Lamivudine (ABC/3TC) 60mg/30mg (Paediatric)

Level of Care Level

Clinic 30 67 9 20 2 4 4 9 45 100 Clinic 0 0 0 0 1 1

HC 2s 207 88 9 4 7 3 12 5 235 100 HC 2s 0 2 2 0 2 6

HC 3s 234 31 173 23 116 15 238 31 761 100 HC 3s 132 9 0 1 0 142

HC 4s 25 18 39 28 22 16 55 39 141 100 HC 4s 37 0 0 0 0 37




Total 571 43 256 19 163 12 339 26 1329 100

Owner Comments: Abacavir/Lamivudine (ABC/3TC) 60mg/30mg (Paediatric)

Govt 178 23 189 25 112 15 287 38 766 100

PNFP 203 58 56 16 49 14 42 12 350 100

PFP 83 90 3 3 2 2 4 4 92 100

NGOs 19 73 4 15 0 0 3 12 26 100

Not Assigned 88 93 4 4 0 0 3 3 95 100

Total 571 43 256 19 163 12 339 26 1329 100

Mainly PFP facilities were stocked out

Facilities with appropriate stock increased to 12% in January-February from 9% in the previous quarter October-December

Govt facilities were the largest over stocked facilities

The Dec'16-Jan'17 ARV Bi-monthly report indicated 22% of facilities had appropriate stock


0 <2 2-4 >4 Total

Stockout facilities reduced from 59% in the previous quarter October-December to 43% in January-February

Stockedout facilities increased from 53% in the previous quarter October-December to 39% in January-February.

Appropriate stock levels increased to 14% in Jan-Feb from 9% in October-December

The Dec'16-Jan'17 ARV Bi-monthly report indicated 21% of facilities had appropriate stock

Government HC3s remain the most over stocked facilities, at 30% (>4MOS) and majority in number(>8MOS)



0 <2 2-4 >4 Total


Ownership


(RHZE) blister strip 150/75/400/275 mg (RHZE) blister strip 150/75/400/275 mg

Level of Care Level

Clinic 32 74 5 12 3 7 3 7 43 100 Clinics 0 2 0 0 0 2

HC 2s 210 91 6 3 0 0 15 7 231 100 HC 2s 0 5 0 1 0 6

HC 3s 281 41 98 14 88 13 219 32 686 100 HC 3s 129 25 1 0 0 155

HC 4s 34 26 30 23 30 23 38 29 132 100 HC 4s 22 5 0 0 0 27




Total 651 52 166 13 138 11 293 24 1248 100

Owner Comments: (RHZE) blister strip 150/75/400/275 mg

Govt 222 32 131 19 112 16 231 33 696 100

PNFP 229 69 28 8 20 6 56 17 333 100

PFP 89 86 5 5 3 3 6 6 103 100

NGOs 19 76 2 8 3 12 1 4 25 100

Not Assigned 92 100 0 0 0 0 0 0 92 100

Total 651 52 166 13 138 11 294 24 1249 100

Ownership


RH blister strip 150/75 mg RH blister strip 150/75 mg

Level of Care Level

Clinic 31 76 4 10 3 7 3 7 41 100 Clinic 0 1 1 0 0 2

HC 2s 216 93 5 2 5 2 7 3 233 100 HC 2s 0 5 0 0 0 5

HC 3s 345 49 107 15 74 11 174 25 700 100 HC 3s 107 8 1 1 0 117

HC 4s 41 32 21 16 20 16 46 36 128 100 HC 4s 29 1 0 0 0 30




Total 725 58 165 13 114 9 247 20 1251 100

Owner Comments: RH blister strip 150/75 mg

Govt 279 40 132 19 82 12 210 30 703 100

PNFP 245 73 27 8 29 9 34 10 335 100

PFP 90 92 2 2 3 3 3 3 98 100

NGOs 19 79 4 17 0 0 1 4 24 100


Total 725 58 165 13 114 9 247 20 1251 100

Facilities with appropriate stock increased to 9% in January-february from 6% in the previous quarter October-December 2016

Government and PNFP facilities were the most over stocked facilities (>8MoS)

Lower level facilities (Clinics and HC2s) with RH Blister strip were private facilities

0 <2 2-4 >4 Total

Facilities with stock outs reduced to 58% in January-February from 69% in the previous quarter October-December

Majority of facilities were stocked out(52%), mainly PFP and NGO HC2s

Govt owned HC3s and HC4s and PNFP facilities form the highest proportion of over stocked facilities

Lower level facilities (Clinics and HC2s) with RHZE were private facilities




0 <2 2-4 >4 Total

TB BASKET


Ownership


Depo- Provera Depo- Provera

Level of Care Level

Clinic 28 36 22 29 9 12 18 23 77 100 Clinic 1 1 7 1 2 12

HC 2s 398 22 242 14 189 11 965 54 1794 100 HC 2s 666 51 22 4 29 772

HC 3s 274 29 119 12 91 10 477 50 961 100 HC 3s 333 34 2 1 4 374

HC 4s 18 13 8 6 26 19 85 62 137 100 HC 4s 57 7 0 0 0 64


Regional Hosp 0 0 2 33 0 0 4 67 6 100 Regional Hospital 3 0 0 0 0 3


Total 783 25 417 13 332 11 1603 51 3135 100 Total 1,073 96 33 6 55 1,263

Owner Comments: Depo- Provera

Govt 402 18 278 12 249 11 1353 59 2282 100

PNFP 255 54 57 12 36 8 127 27 475 100 Governement and PNFP facilities were greatly overstocked at 59% and 27% respectively for >4MoS and similarly overstock for

PFP 69 36 54 28 26 14 44 23 193 100 number of facilities with >8MoS

NGOs 15 42 7 19 4 11 10 28 36 100 At central level (NMS), Depo-Provera was appropriately stocked in January 2017 at an average of 6.3 MoS


Total 783 25 417 13 332 11 1603 51 3135 100

Ownership


Sulfadoxine/ Pyrimethamine tablet Sulfadoxine/ Pyrimethamine tablet

Level of Care Level

Clinic 35 49 18 25 4 6 15 21 72 100 Clinic 2 2 4 0 2 10

HC 2s 553 35 176 11 121 8 721 46 1571 100 HC 2s 526 50 8 2 21 607

HC 3s 318 33 122 13 132 14 383 40 955 100 HC 3s 227 31 4 0 2 264

HC 4s 65 43 20 13 29 19 38 25 152 100 HC 4s 21 0 0 0 0 21




Total 1046 36 390 13 308 11 1196 41 2940 100

Owner Comments: Sulfadoxine/ Pyrimethamine tablet

Govt 708 34 170 8 212 10 967 47 2057 100

PNFP 185 36 118 23 64 12 149 29 516 100

PFP 72 41 60 34 19 11 26 15 177 100

NGOs 19 50 8 21 4 11 7 18 38 100

Not Assigned 62 41 34 22 9 6 48 31 153 100

Total 1046 36 390 13 308 11 1197 41 2941 100

Ownership


ORS Sachets with zinc tablet ORS Sachets with zinc tablet

Level of Care Level

Clinic 27 38 27 38 5 7 12 17 71 100 Clinic 0 2 3 1 1 7

HC 2s 350 19 562 30 308 17 638 34 1858 100 HC 2s 329 29 3 4 9 374

HC 3s 191 18 336 31 200 19 349 32 1076 100 HC 3s 149 36 4 2 1 192

HC 4s 51 31 51 31 22 14 39 24 163 100 HC 4s 20 0 0 0 0 20




Total 669 20 1061 32 560 17 1075 32 3365 100 Total 506 73 10 7 17 613

Owner Comments: ORS Sachets with zinc tablet

Govt 409 17 710 29 424 18 882 36 2425 100

PNFP 151 28 188 34 81 15 126 23 546 100

PFP 58 30 95 50 21 11 18 9 192 100

NGOs 12 33 8 22 5 14 11 31 36 100


Total 669 20 1062 32 560 17 1075 32 3366 100

Govt and PNFP HC2s and HC3s most over stocked (>8MOS)

0 <2 2-4 >4 Total

64% of facilities were either overstocked or understocked

41% of facilities were overstocked; mainly HC2s and HC3s

36% were stocked out mainly Regional hospitals

Govt and PNFP HC2s and HC3s most over (>8MOS) stocked




0 <2 2-4 >4 Total

0 <2 2-4 >4 Total

Majority of facilities are overstocked (51%); mainly HC2s and HC4s

RMNCAH BASKET



Ownership


Measles Vaccine Measles Vaccine

Level of Care Level

Clinic 44 83 4 8 1 2 4 8 53 100 HC 2s 0 0 2 0 0 2

HC 2s 616 38 449 28 264 16 295 18 1624 100 HC 3s 126 18 5 0 3 152

HC 3s 229 23 358 36 178 18 239 24 1004 100 HC 4s 125 14 0 0 0 139

HC 4s 41 28 44 30 21 14 41 28 147 100 General Hosp 20 2 0 0 0 22




Total 1021 34 889 30 479 16 601 20 2990 100

Owner Comments: Measles Vaccine

Govt 619 28 699 32 385 18 500 23 2203 100

PNFP 189 38 148 30 80 16 76 15 493 100

PFP 105 75 18 13 7 5 10 7 140 100

NGOs 20 61 5 15 3 9 5 15 33 100

Not Assigned 88 73 19 16 4 3 10 8 121 100

Total 1021 34 889 30 479 16 601 20 2990 100

2-4 >4 Ownership


Misoprostol 200mcg Tablet Misoprostol 200mcg Tablet

Level of Care Level

Clinic 40 77 8 15 0 0 4 8 52 100 Clinic 0 0 1 0 0 1

HC 2s 790 84 34 4 36 4 77 8 937 100 HC 2s 34 10 2 2 1 49

HC 3s 313 45 61 9 69 10 261 37 704 100 HC 3s 179 18 1 0 0 198

HC 4s 38 30 21 17 16 13 52 41 127 100 HC 4s 38 2 0 0 0 40


Regional Hosp 1 9 3 27 3 27 4 36 11 100 Regional Hospital 3 0 0 0 0 3


Total 1250 63 150 8 153 8 429 22 1982 100 Total 260 38 4 2 6 310

Owner Comments: Misoprostol 200mcg Tablet

Govt 848 62 85 6 100 7 340 25 1373 100

PNFP 228 65 31 9 26 7 65 19 350 100

PFP 81 65 23 18 13 10 8 6 125 100 Government and PNFP facilities were the most overstocked (>8MoS)

NGOs 21 81 0 0 2 8 3 12 26 100 Overall median MoS is 1 month with range (0,86) MoS

Not Assigned 72 67 11 10 12 11 13 12 108 100

Total 1250 63 150 8 153 8 429 22 1982 100

Ownership


Amoxicillin dispersible 125mg tablet Amoxicillin dispersible 125mg tablet

Level of Care Level

Clinic 39 75 7 14 5 10 1 2 52 100 Clinic 83 9 0 0 3 95

HC 2s 744 64 166 14 106 9 152 13 1168 100 HC 2s 57 9 2 0 1 69

HC 3s 532 63 124 15 67 8 123 15 846 100 HC 3s 8 0 0 0 0 8

HC 4s 92 68 17 13 13 10 13 10 135 100 HC 4s 2 1 0 0 0 3




Total 1513 64 341 15 196 8 302 13 2352 100

Owner Comments: Amoxicillin dispersible 125mg tablet

Govt 1062 61 259 15 167 10 248 14 1736 100

PNFP 275 76 42 12 13 4 32 9 362 100

PFP 84 69 21 17 9 7 7 6 121 100

NGOs 22 92 1 4 0 0 1 4 24 100

Not Assigned 70 64 18 17 7 6 14 13 109 100 Overall median MoS is 1 month with range (0,60) MoS

Total 1513 64 341 15 196 8 302 13 2352 100

stockout of facilitis reduced to 64% in January-February from 70% in the previous quarter of October-December

The new guidelines have shifted from using 125mg to 250mg tablet; a letter to this effect was sent out

to facilities

Government facilities were mainly overstocked (>8MoS)

Facilities can report stock status of 250mg tablets using the current tool until it is updated


0 <2 2-4 >4 Total

0 <2 Total

Largest percentage of facilities (63%) were stocked out; mainly NGO's and HC2s

Misoprostol was appropriately stocked at 4.5 MoS at NMS in January- February 2017

Measles vaccine was understocked at NMS in the period October to December 2016

Govt and PNFP facilities most over stocked (>8MOS)



0 <2 2-4 >4 Total

64% of facilities were either stockedout or understocked



Ownership


Ceftriaxone 1g Injection Ceftriaxone 1g Injection

Level of Care Level

Clinic 27 40 35 52 3 5 2 3 67 100 Clinic 0 0 1 0 0 1

HC 2s 151 41 169 46 26 7 25 7 371 100 HC 2s 0 7 1 0 2 10

HC 3s 73 32 102 44 31 13 26 11 232 100 HC 3s 0 16 2 0 0 18

HC 4s 56 36 65 42 19 12 15 10 155 100 HC 4s 9 2 0 0 0 11




Total 371 37 462 45 101 10 82 8 1016 100 Total 13 28 4 0 3 48

Owner Comments: Ceftriaxone 1g Injection

Govt 66 34 85 44 20 10 21 11 192 100

PNFP 156 33 208 43 63 13 52 11 479 100

PFP 60 33 107 59 10 6 4 2 181 100 PNFP facilities were the main overstocked (8MOS)

NGOs 16 44 16 44 2 6 2 6 36 100 Overall median MoS is 1 month with range (0,19) MoS

Not Assigned 73 57 46 36 7 5 3 2 129 100

Total 371 37 462 45 102 10 82 8 1017 100

Ownership


Oxytocin Injection Oxytocin Injection

Level of Care Level

Clinic 39 75 7 14 5 10 1 2 52 100 HC 2s 0 21 6 2 1 30

HC 2s 149 48 71 23 38 12 52 17 310 100 HC 3s 233 21 3 0 0 257

HC 3s 287 33 125 15 108 13 344 40 864 100 HC 4s 21 1 0 0 0 22

HC 4s 38 28 28 21 31 23 38 28 135 100 General Hosp 8 4 0 0 1 13




Total 572 37 283 18 213 14 467 30 1535 100

Owner Comments: Oxytocin Injection

Govt 261 32 90 11 106 13 357 44 814 100

PNFP 165 38 121 28 71 16 82 19 439 100

PFP 64 47 38 28 18 13 15 11 135 100

NGOs 15 47 6 19 5 16 6 19 32 100


Total 573 37 283 18 213 14 467 30 1536 100

Ownership


Mama Kit Mama Kit

Level of Care Level

Clinic 41 85 2 4 3 6 2 4 48 100 Clinic 0 0 2 0 0 2

HC 2s 777 79 71 7 38 4 103 10 989 100 HC 2s 31 41 0 1 5 78

HC 3s 423 46 144 16 127 14 236 25 930 100 HC 3s 104 45 1 3 1 154

HC 4s 52 34 36 24 19 13 44 29 151 100 HC 4s 20 2 0 0 0 22

General Hosp 46 53 11 13 10 12 20 23 87 100 General Hospital 4 5 0 0 0 9



Total 1394 61 275 12 201 9 409 18 2279 100 Total 160 93 3 4 8 268

Owner Comments: Mama Kit

Govt 968 59 216 13 168 10 277 17 1629 100

PNFP 240 61 26 7 20 5 111 28 397 100

PFP 87 76 13 11 8 7 7 6 115 100

NGOs 19 68 2 7 1 4 6 21 28 100


Total 1394 61 275 12 201 9 409 18 2279 100

Govt and PNFP Clinics and HC2s formed the larger part of the overly (>8MOS) stocked

0 <2 2-4 >4 Total

61% of the facilities were stocked out

Stocked out facilities reduced to 37% in January-February 2017 from 53% in the previous quarter of October-December 2016

Govt owned HC3s and HC4s and PNFP HC3s form the most over stocked facilities (>8MOS)


Facilities with appropriate stock increased to 10% in January-February 2017 from 4% in the previous quarter of October-December 2016


0 <2 2-4 >4 Total

0 <2 2-4 >4 Total

82% of facilities were either stocked out or overstocked; mainly PFP facilities.



2-4 >4 Ownership


Determine HIV Screening test Determine HIV Screening test

Level of Care Level

Clinic 16 21 38 51 13 17 8 11 75 100 Clinic 0 1 1 0 0 2

HC 2s 625 45 332 24 198 14 227 16 1382 100 HC 2s 85 15 6 2 2 110

HC 3s 155 14 336 31 221 21 361 34 1073 100 HC 3s 145 23 1 0 0 169

HC 4s 13 8 61 37 31 19 59 36 164 100 HC 4s 29 0 0 0 0 29




Total 849 29 852 30 495 17 696 24 2892 100

Owner Comments: Determine HIV Screening test

Govt 623 31 528 26 321 16 546 27 2018 100

PNFP 122 24 169 33 126 25 95 19 512 100 At central level (NMS) Determine was 6.1 MoS

PFP 44 24 88 48 28 15 25 14 185 100

NGOs 13 38 8 24 5 15 8 24 34 100

Not Assigned 48 33 59 41 15 10 22 15 144 100

Total 850 29 852 30 495 17 696 24 2893 100

Ownership


Stat -pack HIV Confirmatory rapid tests Stat -pack HIV Confirmatory rapid tests

Level of Care Level

Clinic 24 38 17 27 13 20 10 16 64 100 Clinic 0 1 6 1 0 8

HC 2s 795 70 74 7 65 6 210 18 1144 100 HC 2s 86 37 13 5 2 143

HC 3s 406 42 143 15 139 14 285 29 973 100 HC 3s 156 40 3 0 1 200

HC 4s 60 38 35 22 20 13 42 27 157 100 HC 4s 22 2 0 0 0 24




Total 1354 54 314 13 261 10 583 23 2512 100

Owner Comments: Stat -pack HIV Confirmatory rapid tests

Govt 1012 58 187 11 166 10 390 22 1755 100

PNFP 195 42 76 17 61 13 129 28 461 100

PFP 64 43 29 19 22 15 35 23 150 100

NGOs 13 46 4 14 4 14 7 25 28 100

Not Assigned 71 60 18 15 8 7 22 19 119 100

Total 1355 54 314 13 261 10 583 23 2513 100

Ownership


Unigold HIV RDT Tie-breaker test Cotrimoxazole 960mg

Level of Care Level

Clinic 24 44 13 24 6 11 11 20 54 100 Clinic 1 2 6 0 1 10

HC 2s 804 81 43 4 48 5 102 10 997 100 HC 2s 43 17 9 2 2 73

HC 3s 302 39 80 10 105 14 283 37 770 100 HC 3s 157 35 3 0 0 195

HC 4s 46 35 22 17 14 11 51 38 133 100 HC 4s 31 1 0 0 0 32




Total 1253 59 184 9 196 9 481 23 2114 100 Total 237 62 19 3 9 330

Owner Comments: Unigold HIV RDT

Govt 911 61 109 7 132 9 339 23 1491 100

PNFP 186 50 45 12 39 11 100 27 370 100

PFP 67 53 21 17 14 11 25 20 127 100

NGOs 13 57 3 13 1 4 6 26 23 100


Total 1254 59 184 9 196 9 481 23 2115 100

HC2s form the largest percentage of stockout facilities

At central level (NMS), unigold was 3.8 MoS as of January 2017

Govt and PNFP owned HC2s and HC3s formed of the overly (>8MOS) stocked facilities

0 <2 2-4 >4 Total

Majority of facilities were stocked out (59%)

A larger percentage of the facilities were stocked out (54%)

Govt and PNFP facilities formed the larger part of the over stocked (>8MOS) facilities

At NMS Stat Pack is over stocked at (11.5MoS)




0 <2 2-4 >4 Total

0 <2 Total

Majority of the facilities were either stocked out or understocked (54%)

Govt and PNFP facilities formed the larger part of the overly (>8MOS) stocked


LAB BASKET



Ownership


CD4 reagent Specify CD4 reagent Specify

Level of Care Level

Clinic 39 87 1 2 1 2 4 9 45 100 Clinic 0 1 1 2 0 4

HC 2s 226 96 3 1 3 1 3 1 235 100 HC 2s 0 2 0 1 0 3

HC 3s 142 90 5 3 1 1 9 6 157 100 HC 3s 0 7 0 0 0 7

HC 4s 80 70 12 10 5 4 18 16 115 100 HC 4s 11 1 0 0 0 12




Total 595 86 32 5 17 3 46 7 690 100

Owner Comments: CD4 reagent Specify

Govt 97 68 16 11 8 6 22 15 143 100

PNFP 296 89 11 3 7 2 18 5 332 100

PFP 96 96 1 1 2 2 1 1 100 100

NGOs 19 79 2 8 0 0 3 13 24 100

Not Assigned 87 96 2 2 0 0 2 2 91 100

Total 595 86 32 5 17 3 46 7 690 100

Ownership


Malaria Rapid Diagnostic tests Malaria Rapid Diagnostic tests

Level of Care Level

Clinic 23 36 26 41 5 8 10 16 64 100 Clinic 2 0 5 0 0 7

HC 2s 355 20 478 27 301 17 619 35 1753 100 HC 2s 266 58 5 4 13 346

HC 3s 152 14 332 31 176 16 410 38 1070 100 HC 3s 192 55 2 0 1 250

HC 4s 37 23 51 32 22 14 50 31 160 100 HC 4s 22 1 0 0 0 23




Total 625 19 950 29 528 16 1135 35 3238 100

Owner Comments: Malaria Rapid Diagnostic tests

Govt 412 18 644 28 395 17 854 37 2305 100

PNFP 103 18 147 26 97 17 212 38 559 100

PFP 50 28 88 50 15 9 24 14 177 100

NGOs 17 44 12 31 3 8 7 18 39 100

Not Assigned 43 27 59 37 18 11 38 24 158 100

Total 625 19 950 29 528 16 1135 35 3238 100

How many MOS does over stock (> 8MOS) at push facilities (HC2s and HC3s) translate into at higher levels for RDTs?

Ownership


ZN reagent for AFB ZN reagent for AFB

Level of Care Level

Clinic 37 88 3 7 1 2 1 2 42 100 Clinic 0 0 1 0 0 1

HC 2s 213 94 7 3 3 1 4 2 227 100 HC 2s 0 1 0 0 0 1

HC 3s 513 76 65 10 57 8 44 7 679 100 HC 3s 22 5 0 1 0 28

HC 4s 84 79 9 9 7 7 6 6 106 100 HC 4s 4 0 0 0 0 4




Total 965 81 94 8 74 6 59 5 1192 100

Owner Comments: ZN reagent for AFB

Govt 483 74 67 10 57 9 45 7 652 100

PNFP 282 87 21 6 13 4 10 3 326 100

PFP 90 96 3 3 0 0 1 1 94 100

NGOs 20 87 1 4 1 4 1 4 23 100

Not Assigned 90 93 2 2 3 3 2 2 97 100

Total 965 81 94 8 74 6 59 5 1192 100

Majority of facilities were stocked out (81%)

Facilities with appropraite stock improved to 6% from 3% in the previous quarter

Govt HC3s most over (>8MOS) stocked


Therefore; computing MOS using the above figures; we find that the stock at push facilities (with over 8 MOS) translates into:

6 MOS at HC4s; 9 MOS at General Hospitals and 3 MOS at RRHs


0 <2 2-4 >4 Total

Malaria RDTs at NMS were (3MoS) and JMS (3.3MoS)

Govt and PNFP facilities formed the larger part of the overly (>8MOS) stocked


The median stock on hand for the over stocked (>8MOS) push facilities was 2150 test kits.

The median AMC of ACTs at HC4s, General Hospitals and Regional Referral Hospitals were 351, 250 and 800 respectively.

0 <2 2-4 >4 Total

Larger percentage of the facilities overstocked (35%)

However, the CD4 reagent is not specified



0 <2 2-4 >4 Total

Majority of the facilities were stocked out (86%)



Ownership


Blood 450 ml Blood 450 ml

Level of Care Level

Clinic 37 100 0 0 0 0 0 0 37 100 Clinic 0 0 0 0 0 0

HC 2s 224 99 2 1 0 0 0 0 226 100 HC2s 0 0 0 0 0 0

HC 3s 152 97 1 1 1 1 2 1 156 100 HC 3s 0 2 0 0 0 2

HC 4s 96 86 10 9 3 3 3 3 112 100 HC 4s 2 0 0 0 0 2


Regional Hosp 5 63 2 25 1 13 0 0 8 100 Total 3 3 0 0 0 6

Not Assigned 53 100 0 0 0 0 0 0 53 100

Total 629 94 30 5 5 1 7 1 671 100

Owner Comments: Blood 450 ml

Govt 119 83 16 11 4 3 4 3 143 100

PNFP 304 96 9 3 1 0 3 1 317 100

PFP 93 97 3 3 0 0 0 0 96 100

NGOs 21 91 2 9 0 0 0 0 23 100

Not Assigned 92 100 0 0 0 0 0 0 92 100

Total 629 94 30 5 5 1 7 1 671 100


0 <2 2-4 >4 Total

Majority of the facilities were stocked out (94%)



ministry of health pharmacy division january … 2017... · 2017-04-13 · determine hiv screening...

Documents